Person who experienced the adverse event (patient)
| Event ID | CASE | I F COD | FOLL SEQ | IMAGE | EVENT DT | MFR DT | FDA DT | REPT COD | MFR NUM | MFR SNDR | AGE | AGE COD | GNDR COD | E SUB | WT | WT COD | REPT DT | OCCP COD | DEATH DT | TO MFR | CONFID | REPORTER COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 4413687 | 4187703 | I | 4413687-4 | 20040319 | 20040322 | 20040630 | PER | 04P-163-0254221-00 | PPD PHARMACOVIGILANCE | 53 | YR | F | N | 191 | LBS | 20040322 |
Drug(s) used by person
| Event ID | DRUG SEQ | ROLE COD | DRUGNAME | VAL VBM | ROUTE | DOSE VBM | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 4413687 | 1005069755 | PS | HUMIRA | 1 | SUBCUTANEOUS | 40 MG, 1 IN 2 WK, SUBCUTANEOUS | N | D | |||
| 4413687 | 1005095626 | C | HYDROXYCHLOROQUINE PHOSPHATE | 2 | |||||||
| 4413687 | 1005095628 | C | METHOTREXATE | 1 | |||||||
| 4413687 | 1005095630 | C | FOLIC ACID | 1 | |||||||
| 4413687 | 1005095632 | C | ROFECOXIB | 1 | |||||||
| 4413687 | 1005095634 | C | LOSARTAN POTASSIUM | 1 | |||||||
| 4413687 | 1005095635 | C | ZOCOR | 1 | |||||||
| 4413687 | 1005095637 | C | MULTIVITAMIN | 1 |
Indications of drugs used
| Event ID | DRUG SEQ | INDI PT |
|---|---|---|
| 4413687 | 1005069755 | RHEUMATOID ARTHRITIS |
Outcome of event
| no results found |
Reactions reported
| Event ID | PT |
|---|---|
| 4413687 | NASOPHARYNGITIS |
Reporting Sources (this data is often not reported and may therefore be missing here)
| Event ID | RPSR COD |
|---|---|
| 4413687 | CSM |
Therapies reported
| Event ID | DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|
| 4413687 | 1005069755 | 20031229 | 20040322 |